Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 2,312 shares at $135.76 ($317K) on 2020-05-18, disclosed to the SEC on 2020-05-21.
Seasonal sale ($317k) by Director — this insider has traded RGEN in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.76 | 712 | $97K | 30.5% |
| 2 | $135.76 | 712 | $97K | 30.5% |
| 3 | $136.92 | 160 | $22K | 6.9% |
| 4 | $138.60 | 269 | $37K | 11.8% |
| 5 | $139.32 | 122 | $17K | 5.4% |
| 6 | $140.62 | 180 |
| $25K |
| 8.0% |
| 7 | $141.45 | 77 | $11K | 3.4% |
| 8 | $142.45 | 80 | $11K | 3.6% |
| Total | $137.16 avg | 2,312 | $317K | 100% |
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |